CDK6 and lung cancer: miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6 [31], while miR-145 can cause cell cycle arrest at the G0-G1 phase, decrease the S-phase, and inhibit proliferation [27].